Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT04255836 · UNKNOWN
Trial details
- NCT number
- NCT04255836
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2022-09-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.